SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company's total revenue for the quarter ended December 2022 saw a slight change in the total revenue, having registered a total revenue of Rs. 1306.00 millions.Profit for the quarter ended December 2022 rises by 51.25% to Rs. 591.70  millions from Rs. 391.20 millions.OP of the company witnessed a marginal growth to 808.70 millions from 620.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1306.00 1282.20 1.86 3839.40 4161.20 -7.73 5280.60 4826.80 9.40
Other Income 293.60 85.40 243.79 867.80 462.90 87.47 565.50 186.20 203.71
PBIDT 808.70 620.20 30.39 2418.20 2274.80 6.30 2761.70 2325.50 18.76
Interest 0.40 0.20 100.00 0.90 0.70 28.57 0.90 1.70 -47.06
PBDT 808.30 620.00 30.37 2417.30 2274.10 6.30 2760.80 2323.80 18.81
Depreciation 64.70 63.10 2.54 193.50 188.20 2.82 257.70 224.40 14.84
PBT 743.60 556.90 33.52 2223.80 2085.90 6.61 2503.10 2099.40 19.23
TAX 151.90 165.70 -8.33 424.60 497.60 -14.67 624.40 537.10 16.25
Deferred Tax -16.60 3.00 -653.33 -61.70 8.10 -861.73 8.20 -11.70 -170.09
PAT 591.70 391.20 51.25 1799.20 1588.30 13.28 1878.70 1562.30 20.25
Equity 151.80 151.50 0.20 151.80 151.50 0.20 151.60 151.30 0.20
PBIDTM(%) 61.92 48.37 28.02 62.98 54.67 15.21 52.30 48.18 8.55

Caplin Point Lab Share Price

1772.50 6.05 (0.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×